12.1 Pacemaker, ICD, CRT & Loop Recorders

12.1 Pacemaker, ICD, CRT & Loop Recorders

Permanent cardiac implantable electronic devices (CIEDs) are among the most common procedures performed in electrophysiology (EP) labs and shared hybrid cath/EP suites. For the RCIS, device implant support is a high-frequency Domain C competency: you prepare the room, maintain the sterile field, operate fluoroscopy, monitor hemodynamics and rhythm, anticipate equipment needs, and assist the operator with lead delivery and generator placement. Programming, interrogation, and formal device analysis are typically RCES (Registered Cardiac Electrophysiology Specialist) scope in dedicated EP labs—but many hospitals cross-train RCIS staff to assist with basic pacing checks, and CCI expects you to recognize device types, lead anatomy, procedural steps, and complications even when you are not the primary programmer.

Device Classification and Clinical Purpose

Understanding why a device is implanted drives every procedural expectation in the lab.

Single-chamber pacing (VVI or VVIR) is used when atrial sensing is unnecessary—common in chronic atrial fibrillation with slow ventricular response. Dual-chamber pacing (DDD or DDDR) maintains AV synchrony and is preferred in sinus-node dysfunction with intact AV conduction. ICDs deliver tiered therapy: antitachycardia pacing (ATP) for ventricular tachycardia, then high-energy shocks for ventricular fibrillation. CRT (with or without defibrillator capability—CRT-P vs CRT-D) paces the left ventricle through a lead advanced into a lateral or posterolateral cardiac vein via the coronary sinus, correcting the electrical delay of left bundle branch block.

Venous Access, Lead Pathways, and Fluoroscopic Landmarks

Permanent device implants use central venous access, not arterial. The operator most commonly cannulates the subclavian vein (infraclavicular approach), axillary vein (safer for avoiding subclavian crush injury), or cephalic vein (cut-down at the deltopectoral groove). The lead is advanced through the vein into the superior vena cava (SVC), through the right atrium (RA), across the tricuspid valve, and into the right ventricle (RV).

Ventricular Lead Position

The RV apex has historically been the default target—easily reached and stable—but mid-septal or outflow-tract positions are increasingly used to reduce tricuspid regurgitation and improve pacing hemodynamics. On fluoroscopy in the left anterior oblique (LAO) projection, an apical lead points toward the cardiac apex; in right anterior oblique (RAO), the lead curves along the septum. The RCIS confirms stable lead position before the operator deploys the active or passive fixation mechanism (screw-in helix or tines).

Atrial Lead Position

Atrial leads are positioned in the right atrial appendage or lateral RA wall. On fluoroscopy, the atrial lead should demonstrate a gentle J-curve in the appendage without prolapsing through the tricuspid valve during respiration.

ICD Coil Anatomy

ICD leads include a ring or coil electrode in the RV body for defibrillation and often a superior vena cava (SVC) coil to widen the shock vector across the ventricular myocardium. Fluoroscopy shows the radiopaque coil segments along the SVC and RV. The RCIS must handle these leads carefully—kinking or damaging the coil compromises defibrillation efficacy.

CRT: Coronary Sinus and LV Lead

CRT implants require coronary sinus cannulation—a specialized EP task where a guide catheter or sheath is advanced from the RA ostium into the coronary sinus, then into a lateral or posterolateral cardiac vein. The LV lead is deployed in the target vein. This step uses left anterior oblique (LAO) and cranial/caudal angulation to visualize the CS and its branches. Phrenic nerve stimulation during LV lead testing is a common reason for repositioning. RCIS support includes maintaining CS sheath stability, preparing contrast injections for venography, and documenting phrenic stimulation if it occurs.

Generator Pocket and Sterile Technique

After leads are positioned and tested, the operator creates a subcutaneous or subpectoral generator pocket, typically in the left infraclavicular region (right-sided pockets are used for specific anatomical or patient-preference reasons). The RCIS maintains strict sterile technique: prep and drape the chest, pass instruments without breaking the field, and ensure all team members observe cap, mask, gown, and glove protocols.

The generator is connected to the leads, seated in the pocket, and secured with sutures. Hemostasis in the pocket prevents hematoma—a serious complication that can lead to infection and device erosion. The RCIS may assist with pocket irrigation, cautery, and suction while monitoring the patient's rhythm and blood pressure.

Intra-Procedural Device Testing (RCIS Recognition Level)

Before final lead fixation, the operator or EP technologist performs pacing and sensing checks using a pacing system analyzer (PSA) or the implantable pulse generator (IPG) programmer:

• Capture threshold: the lowest output (in volts or milliamperes) that consistently depolarizes the myocardium. A high threshold suggests poor lead contact or impending dislodgement.
• Pacing impedance: typically 300–800 Ω for modern leads. Very low impedance suggests insulation breach; very high suggests lead fracture or poor connection.
• Sensing amplitude (R-wave or P-wave): must exceed the programmed sensitivity with adequate margin. Undersensing causes failure to inhibit pacing; oversensing causes inappropriate inhibition or pacing.

The RCIS documents values when asked, recognizes abnormal numbers, and notifies the operator if sudden hemodynamic deterioration or loss of capture occurs during testing.

Implantable Loop Recorders

ILRs (e.g., Reveal LINQ, BioMonitor) are miniature devices inserted through a small incision in the left parasternal or axillary subcutaneous tissue. They continuously record cardiac rhythm for up to several years to diagnose unexplained syncope, atrial fibrillation after cryptogenic stroke, or palpitations. There are no transvenous leads—the procedure is shorter and uses local anesthesia. RCIS support includes sterile prep of the insertion site, fluoroscopy is usually not required, and the device is injected with a specialized tool. Post-insertion, the operator confirms signal quality on the programmer.

RCIS Versus RCES: Scope Boundaries

In shared cath/EP labs, RCIS staff frequently scrub and assist with device implants alongside electrophysiologists. CCI lists device implant support knowledge under Domain C—not independent device management. Tasks firmly in RCES scope at many institutions include formal device programming, EP study interpretation, ablation mapping support, and complex CRT optimization. The RCIS should know enough to anticipate equipment (PSA cables, programmers, CS sheaths, LV lead delivery systems, torque tools, stylets), recognize malpositioned leads on fluoroscopy, and respond to acute complications (perforation, tamponade, pneumothorax from subclavian access). When in doubt about programming parameters, defer to the credentialed EP specialist—but never ignore hemodynamic collapse during lead placement.

Pre-Procedure and Post-Procedure Considerations

Pre-procedure: verify indication, allergies (especially to antibiotics and contrast), anticoagulation plan (many centers hold warfarin or direct oral anticoagulants per protocol), and antibiotic prophylaxis (typically IV cefazolin within 60 minutes of incision for CIED implants per ACC/AHA guidelines). Confirm MRI-conditional device selection if future MRI access is anticipated.

Post-procedure: apply a pressure dressing over the pocket, enforce 24-hour arm immobilization on the ipsilateral side to prevent lead dislodgement, obtain a chest X-ray to confirm lead position and rule out pneumothorax, and monitor for pocket hematoma, infection, or tamponade. Device interrogation before discharge confirms appropriate sensing, pacing, and (for ICD/CRT-D) defibrillation impedance.

Common Complications the RCIS Must Recognize

• Pneumothorax from subclavian venous access—watch for sudden desaturation and absent breath sounds.
• Cardiac perforation and tamponade during active-fixation screw deployment—hypotension, tachycardia, elevated RA pressure, pulsus paradoxus.
• Lead dislodgement—loss of capture on telemetry immediately post-procedure.
• Pocket hematoma or infection—swelling, erythema, fever; may require device extraction.
• Phrenic nerve capture during CRT LV lead testing—hiccups or diaphragmatic stimulation at low output.

Device implant support demands the same vigilance as coronary intervention: sterile discipline, sharp fluoroscopic anatomy recognition, and immediate escalation when hemodynamics change.